Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Plasma phosphorylated tau181 outperforms [18F] fluorodeoxyglucose positron emission tomography in the identification of early Alzheimer disease

European Journal of Neurology(2024)10.1111/ene.16255Source: DataRank Database

Plasma phosphorylated tau181 outperforms [18F] fluorodeoxyglucose positron emission tomography in the identification of early Alzheimer disease is a research paper published in European Journal of Neurology (2024). On theSindex it has a DataRank of 0. It has been cited 8 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access8 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 2.59)OA: goldTopics (30)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (26)

Joseph Therriault ORCID,Antonio Aliaga ORCID,Cécile Tissot ORCID,Stijn Servaes ORCID,Nesrine Rahmouni ORCID

Live enrichment

PubMed:39447157 OpenAlex:https://openalex.org/W4403716428

Fondation Brain Canada

Grant: CFI Project 34874; 33397

Alzheimer's Association

Grant: NIRG‐12‐92090

Alzheimer's Association

Grant: NIRP‐12‐259245

Canadian Institutes of Health Research

Grant: MOP‐11‐51‐31; RFN 152985, 159815, 162303

Fonds de Recherche du Québec - Santé

Grant: FRQS; Chercheur Boursier, 2020‐VICO‐279314

FWCI

2.59

Citation Percentile

0.9%

Citation Trend

2024

2025

2026

goldLicense: cc-by

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ene.16255

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ene.16255

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1111/ene.16255

journalhttps://doi.org/10.1111/ene.16255

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39447157

Fields of Study

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsFrailty in Older Adults

MeSH Terms

AgedAged, 80 and overAlzheimer DiseaseFemaleHumansMaleMiddle AgedPhosphorylationBiomarkersAmyloid beta-Peptidestau ProteinsRadiopharmaceuticalsFluorodeoxyglucose F18Early DiagnosisPositron-Emission TomographyCognitive Dysfunction

Keywords

Positron emission tomographyMedicineCerebrospinal fluidFluorodeoxyglucoseNeuroimagingDementiaNuclear medicinePathologyInternal medicineDiseasePsychiatry

Sustainable Development Goals

SDG 0: Good health and well-being